NASD · Healthcare · Drug Manufacturers - Specialty & Generic · Luxembourg
Alvotech is a small cap company (market value between $300 million and $2 billion) in the Drug Manufacturers - Specialty & Generic industry.
Intrinsic value, DCF valuation, financial health and value investing analysis for the Alvotech stock.
Undervalued: intrinsic value $8.34 per share, market price $4.65, margin of safety 44.2% (as of 2026-10-30).
Discounting its cash flows at 6.4% values the shares at $8.34; the price of $4.65 is 44% below that value, and 86% of that value comes from beyond year five.
1 more funds hold it; the full list is part of the paid plan.
All 84 Drug Manufacturers - Specialty & Generic stocks
ALVO is undervalued (as of the 2026-10-30 close). Discounting its cash flows at 6.4% values the shares at $8.34; the price of $4.65 is 44% below that value, and 86% of that value comes from beyond year five.
$8.34 per share (as of the 2026-10-30 close), against a market price of $4.65. That is a margin of safety of 44.2%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.